Aviva
KURA icon

Aviva’s Kura Oncology KURA Stock Holding History

Aviva’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48,073
Closed -$1.36M – 924
2021
Q1 		$1.36M Buy
48,073
+4,881
+11% +$154K 0.01% 737
2020
Q4 		$1.41M Sell
43,192
-35,014
-45% -$1.23M 0.01% 792
2020
Q3 		$2.4M Sell
78,206
-65,858
-46% -$1.45M 0.01% 622
2020
Q2 		$2.35M Sell
144,064
-104,525
-42% -$1.51M 0.01% 617
2020
Q1 		$2.47M Buy
+248,589
New +$2.85M 0.02% 686

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Aviva's KURA Position: Q2 2021 in Review

Aviva sold out of Kura Oncology (KURA) in Q2 2021, closing a stake of 48,073 shares — an estimated $1.36M sold.

Aviva first reported a position in KURA in Q1 2020 and held it in 5 quarters. The position peaked at $2.47M in Q1 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q2 2021.

  • Aviva reported no remaining Kura Oncology position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 48,073 Kura Oncology shares in Q2 2021, an estimated $1.36M.
  • Aviva first reported a position in Kura Oncology in Q1 2020 and held it in 5 quarters.
  • Aviva's Kura Oncology position peaked at $2.47M in Q1 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.